In the Media

There's a lot of genetic data out there. We're still figuring out how to use and protect it.

The sequence of some 3 billion DNA base pairs that comprise our genome was supposed to be a mosaic, assembled from multiple anonymous people to protect the identity of the volunteer donors. But that’s not how it turned out: One individual’s DNA accounted for the vast majority of…

Mass-market genetic testing has little to offer most people. That’s a big problem for 23andMe.

Under pressure to help combat this public health crisis, the Food and Drug Administration has begun taking steps intended to reduce overdoses and opioid use disorder, but critics warn against use of controversial DNA test. 

Debate over figure connecting genes, race and ethnicity reignites concerns among geneticists about how to represent human diversity.

Six years ago, the National Institutes of Health placed its biggest ever bet on precision medicine, launching a study to enroll over 1 million participants in an ambitious data-gathering gambit unmatched in its scope and diversity.

The class-action suit said the genetic testing company failed to notify customers whose personal information was compiled into “curated” lists that were sold on the dark web.  

Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine. 

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system

Scientists are setting out to collect genetic material from 500,000 people of African ancestry to create what they believe will be the world’s largest database of genomic information from the population.